Age Research, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

008443 20 2

(CUSIP Number)

with copy to:

(Name, Address and Telephone Number of Person Authorized to

Receive Notices and Communications)

June 24, 2004

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)

This Schedule 13D relates to shares of the common stock of Age Research, Inc. (the "Company"). The principal executive offices of the Company are located at 18101 Von Karman Avenue, Suite 330, Irvine, California 92612.

Item 2. Identity and Background 

This Schedule 13D is being filed on behalf of George Lefevre (the "Reporting Person"). The Reporting Person is a principal of NeoTactix, Inc. ("NeoTactix"), a business consulting firm with its business address at 18101Von Karman Avenue, Suite 330, Irvine, California 92612.

During the last five years, the Reporting Person has not been convicted in any criminal proceeding. During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. 

Item 3. Source and Amount of Funds or Other Consideration 

The Reporting Person acquired 2,250,000 shares of the Company's common stock pursuant to the terms and conditions of a Business Consulting Agreement, dated June 23, 2004, entered by and between NeoTactix and the Company. The terms of the transactions are further described in Item 4 below.

On June 23, 2004, the Company and NeoTactix entered into a Business Consulting Agreement (the "Agreement") pursuant to which NeoTactix agreed to provide certain business consulting services to the Company as specified in the Agreement. In exchange for such services, the Company agreed to issue to the Reporting Person 2,250,000 shares of the Company's common stock (the "Shares"). Pursuant to the terms of the Agreement, on June 24, 2004, the Company filed a Form S-8 to register the Shares with the Securities and Exchange Commission. The Shares were issued on June 24, 2004.

Except as disclosed in this Item 4, the Reporting Person has no other plans or proposals which relate to or would result in:

1. The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer;

2. An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries;

3. A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries;

4. Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;

5. Any material change in the present capitalization or dividend policy of the issuer;

6. Any other material change in the issuer's business or corporate structure including but not limited to, if the issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940;

7. Changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person;

8. Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;

9. A class of equity securities of the issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or

10. Any action similar to any of those enumerated above.

Item 5. Interest in Securities of the Issuer 

1. As a result of the transactions referenced in Item 4, the Reporting Person is the owner of 2,250,000 shares of the Company's common stock, representing 9.2% of the Company's outstanding shares of common stock.

2. The Reporting Person has the sole power to vote or to direct the vote and the sole power to dispose or to direct the disposition of 2,250,000 shares of the Company's common stock, representing 9.2% of the Company's outstanding shares of common stock. The Reporting Person does not share any power to vote or to direct the vote, or share any power to dispose or to direct the disposition of any shares of the Company's stock.

3. Not applicable.

4. Not applicable.

5. Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer 

None, except for the Agreement.

Item 7. Material to Be Filed as Exhibits 

Exhibit 1 - Business Consulting Agreement, dated June 23, 2004, by and between the Company and NeoTactix.¹